Aspire Biopharma Holdin-CW27ASBPW Preferred / convertible 13F holders, Q1 2025 (March 31) 27 holders
1 famous investor
$0.06 avg. 13F price*
At the end of Q1 2025 , 27 institutions reported holding Aspire Biopharma Holdin-CW27 (ASBPW) in their 13F filings. The largest holders were Saba Capital Management, L.P. ($72K), Adage Capital Partners Gp, L.L.C. ($71K) and Linden Advisors LP ($66K). One famous investor held it David E. Shaw ( of D. E. Shaw & Co.'s portfolio).
Company Aspire Biopharma Holdin-CW27
CUSIP 738920115
Latest filing quarter Q2 2026 History Number of 13F holders
Total Exit/New Position Q1 2025 Institutions Total Value New Positions 27 $559K Exits 0 $0
Ownership 27 holders Portfolio Manager % of Holder's Portfolio Change Shares Value ▼ Saba Capital Management, L.P. — New 983,603 $72K Adage Capital Partners Gp, L.L.C. — New 1,050,000 $71K Linden Advisors LP — New 899,999 $66K Aristeia Capital, L.L.C. — New 681,516 $50K Sculptor Capital LP — New 2,405,000 $37K Barclays PLC — New 350,000 $31K Periscope Capital Inc. — New 408,567 $30K Verition Fund Management LLC — New 432,757 $29K Clear Street LLC — New 331,064 $22K Taconic Capital Advisors LP — New 300,000 $20K Alberta Investment Management Corp — New 250,000 $17K Mint Tower Capital Management B.V. — New 25,000 $15K D. E. Shaw & Co. — New 199,999 $14K Wolverine Asset Management LLC — New 195,944 $13K Athos Capital Ltd — New 21,383 $12K Context Capital Management, LLC — New 175,000 $12K Polar Asset Management Partners Inc. — New 138,536 $10K LMR Partners LLP — New 125,000 $8K Whitebox Advisors LLC — New 118,750 $8K Clear Street Derivatives LLC — New 106,000 $7K Caas Capital Management LP — New 75,000 $5K Blue Owl Capital Holdings LP — New 50,000 $4K Picton Mahoney Asset Management — New 50,000 $3K OMERS ADMINISTRATION Corp — New 25,000 $2K Flow Traders U.S. LLC — New 14,191 $1K Reyes Financial Architecture, Inc. — New 70 $4 Farther Finance Advisors, LLC — New 10 $1
"% of holder's portfolio" is ASBPW's weight in each manager's 13F, not the share of Aspire Biopharma Holdin-CW27 the manager owns.